PatientsVille.com Logo

HYPOAESTHESIA and Mirtazapine

PatientsVille

HYPOAESTHESIA Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for HYPOAESTHESIA

HYPOAESTHESIA treatment research studies

Mirtazapine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Mirtazapine Side Effects

Completed Suicide (237)
Confusional State (206)
Hyponatraemia (180)
Depression (160)
Overdose (148)
Anxiety (147)
Fall (136)
Dizziness (130)
Agitation (130)
Condition Aggravated (123)
Somnolence (117)
Insomnia (113)
Headache (110)
Serotonin Syndrome (109)
Suicidal Ideation (107)
Fatigue (105)
Loss Of Consciousness (104)
Convulsion (103)
Aggression (103)
Suicide Attempt (100)
Nausea (96)
Oedema Peripheral (93)
Dyspnoea (92)
Weight Increased (90)
Tachycardia (90)
Tremor (84)
Malaise (82)
Vomiting (75)
Restless Legs Syndrome (75)
Myalgia (73)
Alanine Aminotransferase Increased (72)
Cardiac Arrest (71)
Inappropriate Antidiuretic Hormone Secretion (71)
Feeling Abnormal (70)
Toxicity To Various Agents (69)
Asthenia (69)
Diarrhoea (67)
Syncope (62)
Hyperhidrosis (61)
Neuroleptic Malignant Syndrome (61)
Pain In Extremity (61)
Electrocardiogram Qt Prolonged (60)
Pyrexia (59)
Aspartate Aminotransferase Increased (58)
Pulmonary Embolism (57)
Arthralgia (56)
Hypotension (56)
Irritability (56)
Pain (55)
Gait Disturbance (54)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

i have been on citalopram and amatripolineand fluxaitne i have been on 15mg of mirtazapine and tryed 30mg the doc has put me on 45mg and i asked if these tablets dont work what is next hes said shrink as i have tryed all the ones he said but i have

My symptoms were tired, weak, unable to sleep. Was prescribed half of a 15 MG Mirtazapine nightly to help me sleep. Has this drug been successful used as a sleeping aid?

The above comment is too stupid, I actually LOLed at you Pete... lol you gave it 2 days and your complaining about the side-effects? and on 15 mgs? LMAO!!! It takes couple weeks at least to cope with the side-effects; just like m

48 year old male, I have suffered depression all my life. Have used SSRI's for the last ten years with good but mixed results. Last year lost my job due to an episode where I ended up throwing my monitor across the office and have not been able to wo

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

Back pain

Been on 90mg mirtazapine for 6 years twice the recomended dose is this considered safe

Body covered in hives

Does mirtazapine have muscles side effects?

Hi, I have been on mittazapine for 10 days, sleepy , tierd all the time and slugish in response to conversation just horrid feel gastly , head ace, The worst went to bed 11pm took the 15mg pill, went to the loo at 3am and collapse

HYPOAESTHESIA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Interventions: Drug: Amifostine;   Procedure: CyberKnife stereotactic radiosurgery
Outcome Measures: Facial numbness following radiosurgery;   Pain relief following radiosurgery
2 Recruiting Diffusion Tensor Imaging Magnetic Resonance Imaging (DTI MRI) as a Correlate to Pain Relief and Facial Numbness in Patients Following Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention:
Outcome Measure: DTI MRI findings
3 Unknown  A Clinical Outcomes Study to Measure Reduction in Pain and Numbness During Administration of an Amino Acid Formulation in Subjects Diagnosed With Peripheral Neuropathy
Conditions: Diabetic Neuropathy;   Chemotherapy Induced Neuropathy;   HIV Neuropathy;   Trauma Induced Neuropathy
Intervention: Drug: Neuron012703 (Medical Food)
Outcome Measures: VAS;   NTSS-6;   Routine Blood Panel
4 Recruiting Stability of the Cochlear Baha BI300/BA400 Implant System Loaded From 1 Week Post-surgery
Condition: Hearing Loss - Conductive
Interventions: Procedure: One week loading of Bone Anchored Hearing Aid (BAHA);   Device: Cochlear Baha BI300/BA400 Implant System
Outcome Measures: Implant stability;   Soft tissue status;   Skin overgrowth;   Pain around implant;   Numbness around implant
5 Recruiting Clinical Study to Evaluate the Effect of pH on Pain Upon Local Anesthetic Administration.
Condition: Local Anesthetics
Interventions: Drug: Lidocaine;   Drug: normal saline;   Drug: alkalinized lidocaine
Outcome Measures: pain score;   time until hypoesthesia;   time until anesthesia;   pain score upon needle stick.
6 Recruiting Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Condition: Colorectal Cancer
Interventions: Drug: Minocycline;   Drug: Placebo;   Behavioral: Questionnaires;   Behavioral: Sensory Test
Outcome Measure: Reduction of Acute Peripheral Neuropathy During Oxaliplatin-Based Chemotherapy
7 Recruiting Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation
Conditions: Conductive Hearing Loss;   Mixed Hearing Loss;   Single Sided Deafness
Intervention:
Outcome Measures: Numbness around implant, specifically mean Total sensibility;   Length of surgery;   Sum of number of unplanned visits, revision surgeries, medications related to implant, and other treatments requiring medical staff per patient;   Mild/Adverse skin reaction;   Skin condition according to Holgers;   Postoperative complications;   Proportion of patients with complete wound healing at first surgical visit;   Glasgow Benefit Inventory (GBI) scores;   Glasgow Health Status Inventory (GHSI) scores;   Abbreviated profile of hearing aid benefit (APHAB) scores;   Mean hours of use of the sound processor;   Bone conduction (BC) in-situ audiometric thresholds;   Bone conduction (BC) audiometric threshold;   Mean total sensibility around implant;   Implant stability quotient (ISQ);   Time to implant loss;   Patient and Observer scar assessment score
8 Recruiting Safety of Spinal Anesthesia in Patients With Tibial Shaft Fracture
Condition: Tibial Fracture
Interventions: Procedure: General anesthesia;   Procedure: Spinal anesthesia
Outcome Measures: Compartment pressure;   INVOS values after surgery
9 Unknown  Small-fiber Neuropathy in Chronic Kidney Disease
Conditions: Small-Fiber Neuropathy;   Chronic Kidney Disease
Intervention: Other: Skin biopsy
Outcome Measures: The pathology of skin biopsy;   Intraepidermal fiber density;   Autonomic function;   Function of small-fiber sensory nerve
10 Unknown  A Study of Patient Reported Outcomes After Stereotactic Radiosurgical Rhizotomy for Trigeminal Neuralgia
Condition: Trigeminal Neuralgia
Intervention:
Outcome Measure: Patient satisfaction following CyberKnife radiosurgery
11 Recruiting Effectiveness Study of Hydrotherapy Against Pain and Other Symptoms in Diabetes-induced LEAD
Conditions: Diabetes;   Lower Extremity Arterial Disease
Intervention: Other: hydrotherapy
Outcome Measures: Change from the intensity of numbness and cold feeling at 4 weeks. Change from the improvement of the pain index at 4 weeks.;   Change from ankle-brachial index at 4 weeks
12 Recruiting Neuroprotection by Tocotrienols in Type 1 and Type 2 Diabetes Mellitus
Conditions: Diabetic Neuropathy;   Cognitive Impairment
Interventions: Dietary Supplement: Tocotrienol;   Dietary Supplement: Placebo
Outcome Measures: Total Symptoms Score (TSS) (pain, paresthesia, burning, and numbness)of patients with diabetes type 1 and 2 neuropathy.;   Neuropathy Impairment Score (NIS) of patients with diabetes type 1 and 2 neuropathy
13 Unknown  Effect of Intraoperative Infiltration With Bupivacain on the Development of Chronic Pain After Inguinal Hernia Repair
Condition: Chronic Pain
Interventions: Procedure: Infiltration with Saline;   Procedure: Infiltration with Bupivacaine
Outcome Measures: occurrence of chronic pain;   Level of Pain:Pain Matcher®,VAS;Areas of hyperalgesia,hypaesthesia Hospitalization:Length of stay (days) ASA-Classification Beginning of mobilisation (days) Return to work or normal activity (days and %) Quality of life (SF36)
14 Recruiting RFD Versus Cervical Medial Branch Blocks in Chronic Degenerative Neck Pain
Conditions: Facet Joint Arthritis;   Pain;   Radiofrequency Denervation
Interventions: Procedure: Radio Frequency Denervation;   Procedure: Local Anesthesia
Outcome Measures: Mean pain intensity measured on a 11-point Numeric Rating Scale (NRS).;   Patient Global Impression of Change according to a 7-point Likert scale (PGIC).;   Changes in use of pain medication according to the Medication Quantification Scale (MQS).;   Changes in the Neck Disability Index scale (NDI).;   Changes in quality of life and differences between groups by means of RAND 36.;   Improvement in functionality measured by the Patient Specific Functional Scale.;   Change in physical/neurological examination parameters.;   Change in employment status.
15 Unknown  Thoracic Manipulation in Patients With Cervical Radiculopathy
Condition: Cervical Radiculopathy
Interventions: Procedure: Thrust Manipulation - Thoracic Spine;   Procedure: Sham Manipulation
Outcome Measures: Global Rating of Change;   Numeric Pain Rating Scale (Neck & Upper Extremity);   Neck Disability Index;   Cervical Range of Motion;   Deep Neck Flexor Endurance;   Numbness and Tingling Scale
16 Not yet recruiting Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy
Conditions: Peripheral Neuropathy;   Pain;   Paresthesia;   Neuritis
Interventions: Device: active TENS;   Device: placebo TENS
Outcome Measures: Evaluate the effects of TENS in the reduction of symptoms related to peripheral neuropathy due to chemotherapy treatment of a high and moderate neurotoxic potential in cancer patients.;   Evaluate the therapeutic response of TENS in symptoms of paresthesia;   Evaluate the therapeutic response of TENS in activities of the daily lives of patients.;   Evaluate the therapeutic response of TENS in symptoms of neuropathic pain.;   Evaluate the factors associated with better treatment response in paresthesia, in pain and activities of daily living.
17 Unknown  Trial to Evaluate Erectile Function, Fertility and Sperm Count in Male Cyclists Compared to Age Matched Controls
Conditions: Erectile Dysfunction;   Azoospermia
Intervention:
Outcome Measure:
18 Not yet recruiting A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients
Conditions: Taxane-induced Peripheral Neuropathy;   Chemotherapy-induced Peripheral Neuropathy (CIPN);   Early-Stage Breast Carcinoma;   Stage I Breast Cancer;   Stage II Breast Cancer;   Stage III Breast Cancer
Interventions: Procedure: Immediate Acupuncture Group;   Procedure: Delayed Acupuncture Group
Outcome Measures: Response Rate from Baseline in PNQ Score;   Changes in FACT/NTX subscale baseline to 8 weeks;   Changes in EORTC-QLQ-CIPN20 subscale Baseline, 8 Weeks
19 Recruiting Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)
Conditions: Breast Cancer;   Colorectal Cancer
Interventions: Device: Acupuncture using Seirin® needles;   Device: Sham Acupuncture using Park Sham placebo acupuncture device
Outcome Measures: Proportion of colorectal and breast cancer patients in each arm who require dose reduction or discontinuation due to chemotherapy-induced peripheral neuropathy.;   Chemotherapy cumulative relative dose intensity;   Level of neurotoxicity as assessed by the Functional Assessment of Cancer Therapy/ Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) questionnaire;   Neuropathic pain as assessed by Neuropathy Pain Scale (NPS) questionnaire;   Level of nerve conduction;   Serum concentrations of nerve growth factor and other neurotrophic factors
20 Unknown  The Evaluation of Safety and Efficacy of JWHGWT on Diabetic Neuropathy
Condition: Diabetic Neuropathy
Interventions: Drug: placebo;   Drug: JWHGWT
Outcome Measures: Short-form (sf)- McGill pain questionnaire (SF-MPQ);   Nerve conduction study